Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 159,067 |
|
|||||
| News | - | ||||||
| Day High | 1.44 | Low High |
|||||
| Day Low | 1.34 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Immuneering Corporation | IMRX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.01 | 0.72% | 1.39 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.39 | 1.34 | 1.44 | 1.39 | 1.38 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,407 | 159,067 | $ 1.36 | $ 217,010 | - | 1.34 - 11.92 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:49:24 | formt | 209 | $ 1.39 | USD |
Immuneering Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 40.7M | 29.28M | - | 0 | -53.47M | -1.83 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Immuneering News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IMRX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.44 | 1.5243 | 1.34 | 1.42 | 176,764 | -0.05 | -3.47% |
| 1 Month | 1.73 | 1.7783 | 1.34 | 1.53 | 195,267 | -0.34 | -19.65% |
| 3 Months | 6.78 | 6.78 | 1.34 | 2.35 | 840,746 | -5.39 | -79.50% |
| 6 Months | 6.55 | 8.89 | 1.34 | 2.71 | 424,734 | -5.16 | -78.78% |
| 1 Year | 7.18 | 11.92 | 1.34 | 3.73 | 252,595 | -5.79 | -80.64% |
| 3 Years | 19.50 | 33.99 | 1.34 | 7.15 | 147,033 | -18.11 | -92.87% |
| 5 Years | 19.50 | 33.99 | 1.34 | 7.15 | 147,033 | -18.11 | -92.87% |
Immuneering Description
| Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to leading pharmaceutical and biotechnology companies. |
